{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:49:37Z","timestamp":1782312577506,"version":"3.54.5"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chemoresistance in treatment of colorectal liver metastases (CRLM) poses a major challenge in preventing disease relapse, with up to 80% of patients developing drug resistance over the course of treatment. Proteomic signatures of responsive vs. non-responsive metastases can provide insights into functional expression patterns, potentially identifying biomarkers for therapy efficacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A total of 33 CRLM tissue samples from 31 patients were subjected to histopathological and proteomic analysis. The patients were included in the study after undergoing preoperative treatment (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200928), including platinum-based chemotherapy (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200919), non-platinum-based chemotherapy (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098), as well as targeted therapies (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200920), or without preoperative therapy (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20095). Based on Rubbia-Brandt criteria and vital tumor cell percentage, CRLM were categorized to major (MR), partial (PR) and no response (NR) groups. Proteomic analysis was conducted using label-free mass spectrometry (LFQ-MS), followed by clustering according to histological response and distinct treatment regimens.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Proteomic analysis revealed significant differential protein expression of 607 proteins linked to distinct histopathological response types. CRLM responsive to chemotherapy displayed marked enrichment (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009\u2264\u20090.01) in pathways associated with immune infiltration, ECM matrix organization, the complement system, and apolipoprotein-associated processes, indicative of distinct stromal and immune invasion patterns with multimodal importance of cell adhesion proteins. In contrast, attenuated expression of proteins enriched in pathways of mitochondrial translation initiation, elongation and termination was detectable.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CRLM exhibited distinct proteomic phenotypes based on their histopathological response to preoperative systemic therapy largely independent of chemotherapy regimens. This proteomic profiling establishes a foundation for identifying critical biomarker profiles by nominating protein markers for major chemotherapy response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-026-07945-1","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T09:02:52Z","timestamp":1772701372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Proteomic profiling of colorectal liver metastases reveals histopathological response-specific molecular signatures of chemotherapy efficacy"],"prefix":"10.1186","volume":"24","author":[{"given":"Agnes K.","family":"B\u00f6hm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Skrip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Strobl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas K.","family":"Wieland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Papke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Sers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik P.","family":"Modest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Moosburner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp K.","family":"Haber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Krenzien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanael","family":"Raschzok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzel","family":"Sch\u00f6ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Malinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingolf","family":"Sack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Pratschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9355-937X","authenticated-orcid":false,"given":"Igor M.","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl H.","family":"Hillebrandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"7945_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, Vignat J, Ferlay J, Murphy N, Bray F. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72:338\u201344.","journal-title":"Gut"},{"key":"7945_CR2","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.jcmgh.2023.08.012","volume":"16","author":"RK Patel","year":"2023","unstructured":"Patel RK, Rahman S, Schwantes IR, Bartlett A, Eil R, Farsad K, Fowler K, Goodyear SM, Hansen L, Kardosh A, Nabavizadeh N, Rocha FG, Tsikitis VL, Wong MH, Mayo SC. Updated Management of Colorectal Cancer Liver Metastases: Scientific Advances Driving Modern Therapeutic Innovations. Cell Mol Gastroenterol Hepatol. 2023;16:881\u201394.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"7945_CR3","doi-asserted-by":"publisher","first-page":"761","DOI":"10.5306\/wjco.v11.i10.761","volume":"11","author":"J Martin","year":"2020","unstructured":"Martin J, Petrillo A, Smyth EC, Shaida N, Khwaja S, Cheow HK, Duckworth A, Heister P, Praseedom R, Jah A, Balakrishnan A, Harper S, Liau S, Kosmoliaptsis V, Huguet E. Colorectal liver metastases: Current management and future perspectives. World J Clin Oncol. 2020;11:761\u2013808.","journal-title":"World J Clin Oncol"},{"key":"7945_CR4","doi-asserted-by":"crossref","unstructured":"Ivey GD, Johnston FM, Azad NS, Christenson ES, Lafaro KJ, Shubert CR. Current surgical management strategies for colorectal cancer liver metastases. Cancers (Basel). 2022;14.","DOI":"10.3390\/cancers14041063"},{"key":"7945_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41421-021-00312-y","volume":"7","author":"LH Che","year":"2021","unstructured":"Che LH, Liu JW, Huo JP, Luo R, Xu RM, He C, Li YQ, Zhou AJ, Huang P, Chen YY, Ni W, Zhou YX, Liu YY, Li HY, Zhou R, Mo H, Li JM. A single-cell atlas of liver metastases of colorectal cancer reveals reprogramming of the tumor microenvironment in response to preoperative chemotherapy. Cell Discov. 2021;7:80.","journal-title":"Cell Discov"},{"key":"7945_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejca.2018.12.019","volume":"109","author":"DP Modest","year":"2019","unstructured":"Modest DP, Pant S, Sartore-Bianchi A. Treatment sequencing in metastatic colorectal cancer. Eur J Cancer. 2019;109:70\u201383.","journal-title":"Eur J Cancer"},{"key":"7945_CR7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41419-019-2081-4","volume":"10","author":"M Kleih","year":"2019","unstructured":"Kleih M, Bopple K, Dong M, Gaissler A, Heine S, Olayioye MA, Aulitzky WE, Essmann F. Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells. Cell Death Dis. 2019;10:851.","journal-title":"Cell Death Dis"},{"key":"7945_CR8","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","volume":"27","author":"E Van Cutsem","year":"2016","unstructured":"Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, Aranda Aguilar E, Bardelli A, Benson A, Bodoky G, Ciardiello F, D\u2019Hoore A, Diaz-Rubio E, Douillard JY, Ducreux M, Falcone A, Grothey A, Gruenberger T, Haustermans K, Heinemann V, Hoff P, Kohne CH, Labianca R, Laurent-Puig P, Ma B, Maughan T, Muro K, Normanno N, Osterlund P, Oyen WJ, Papamichael D, Pentheroudakis G, Pfeiffer P, Price TJ, Punt C, Ricke J, Roth A, Salazar R, Scheithauer W, Schmoll HJ, Tabernero J, Taieb J, Tejpar S, Wasan H, Yoshino T, Zaanan A. D. Arnold, ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27:1386\u2013422.","journal-title":"Ann Oncol"},{"key":"7945_CR9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s13046-021-02130-2","volume":"40","author":"J Zhou","year":"2021","unstructured":"Zhou J, Ji Q, Li Q. Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies. J Exp Clin Cancer Res. 2021;40:328.","journal-title":"J Exp Clin Cancer Res"},{"key":"7945_CR10","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.3748\/wjg.v24.i34.3834","volume":"24","author":"K Van der Jeught","year":"2018","unstructured":"Van der Jeught K, Xu HC, Li YJ, Lu XB, Ji G. Drug resistance and new therapies in colorectal cancer. World J Gastroenterol. 2018;24:3834\u201348.","journal-title":"World J Gastroenterol"},{"key":"7945_CR11","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nature11156","volume":"486","author":"S Misale","year":"2012","unstructured":"Misale S, Yaeger R, Hobor S, Scala E, Janakiraman M, Liska D, Valtorta E, Schiavo R, Buscarino M, Siravegna G, Bencardino K, Cercek A, Chen CT, Veronese S, Zanon C, Sartore-Bianchi A, Gambacorta M, Gallicchio M, Vakiani E, Boscaro V, Medico E, Weiser M, Siena S, Di Nicolantonio F, Solit D, Bardelli A. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer. Nature. 2012;486:532\u20136.","journal-title":"Nature"},{"key":"7945_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.21873\/cgp.20126","volume":"16","author":"Z Li","year":"2019","unstructured":"Li Z, Chen Y, Ren WU, Hu S, Tan Z, Wang Y, Chen Y, Zhang J, Wu J, Li T, Xu J, Ying X. Transcriptome Alterations in Liver Metastases of Colorectal Cancer After Acquired Resistance to Cetuximab. Cancer Genomics Proteom. 2019;16:207\u201319.","journal-title":"Cancer Genomics Proteom"},{"key":"7945_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/14789450.2017.1299006","volume":"14","author":"S Fu","year":"2017","unstructured":"Fu S, Liu X, Luo M, Xie K, Nice EC, Zhang H, Huang C. Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identification. Expert Rev Proteom. 2017;14:351\u201362.","journal-title":"Expert Rev Proteom"},{"key":"7945_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41575-024-00934-z","volume":"21","author":"A Canellas-Socias","year":"2024","unstructured":"Canellas-Socias A, Sancho E, Batlle E. Mechanisms of metastatic colorectal cancer. Nat Rev Gastroenterol Hepatol. 2024;21:609\u201325.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7945_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/annonc\/mdl386","volume":"18","author":"L Rubbia-Brandt","year":"2007","unstructured":"Rubbia-Brandt L, Giostra E, Brezault C, Roth AD, Andres A, Audard V, Sartoretti P, Dousset B, Majno PE, Soubrane O, Chaussade S, Mentha G, Terris B. Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol. 2007;18:299\u2013304.","journal-title":"Ann Oncol"},{"key":"7945_CR16","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"JR Wisniewski","year":"2009","unstructured":"Wisniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods. 2009;6:359\u201362.","journal-title":"Nat Methods"},{"key":"7945_CR17","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/s41592-020-00998-0","volume":"17","author":"F Meier","year":"2020","unstructured":"Meier F, Brunner AD, Frank M, Ha A, Bludau I, Voytik E, Kaspar-Schoenefeld S, Lubeck M, Raether O, Bache N, Aebersold R, Collins BC, Rost HL, Mann M. diaPASEF: parallel accumulation-serial fragmentation combined with data-independent acquisition. Nat Methods. 2020;17:1229\u201336.","journal-title":"Nat Methods"},{"key":"7945_CR18","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","volume":"53","author":"Y Perez-Riverol","year":"2025","unstructured":"Perez-Riverol Y, Bandla C, Kundu DJ, Kamatchinathan S, Bai J, Hewapathirana S, John NS, Prakash A, Walzer M, Wang S, Vizcaino JA. The PRIDE database at 20 years: 2025 update. Nucleic Acids Res. 2025;53:D543\u201353.","journal-title":"Nucleic Acids Res"},{"key":"7945_CR19","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT, Pyysalo S, Bork P, Jensen LJ, von Mering C. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51:D638\u201346.","journal-title":"Nucleic Acids Res"},{"key":"7945_CR20","doi-asserted-by":"publisher","first-page":"D609","DOI":"10.1093\/nar\/gkae1010","volume":"53","author":"C UniProt","year":"2025","unstructured":"UniProt C. UniProt: the Universal Protein Knowledgebase in 2025. Nucleic Acids Res. 2025;53:D609\u201317.","journal-title":"Nucleic Acids Res"},{"key":"7945_CR21","doi-asserted-by":"crossref","unstructured":"Milacic M, Beavers D, Conley P, Gong C, Gillespie M, Griss J, Haw R, Jassal B, Matthews L, May B, Petryszak R, Ragueneau E, Rothfels K, Sevilla C, Shamovsky V, Stephan R, Tiwari K, Varusai T, Weiser J, Wright A, Wu G, Stein L, Hermjakob H. P. D\u2019Eustachio. The reactome pathway knowledgebase 2024. Nucleic Acids Res. 2024;52:D672\u2013D678.","DOI":"10.1093\/nar\/gkad1025"},{"key":"7945_CR22","doi-asserted-by":"publisher","first-page":"D1519","DOI":"10.1093\/nar\/gkac1009","volume":"51","author":"X Shao","year":"2023","unstructured":"Shao X, Gomez CD, Kapoor N, Considine JM, Grams C, Gao YT, Naba A. MatrisomeDB 2.0: 2023 updates to the ECM-protein knowledge database. Nucleic Acids Res. 2023;51:D1519\u201330.","journal-title":"Nucleic Acids Res"},{"key":"7945_CR23","doi-asserted-by":"crossref","unstructured":"Xu Y, Zhou J, Wu Y, Shen J, Fu X, Liu M, Liang S. New insights into the role of complement system in colorectal cancer (Review). Mol Med Rep. 2025;31.","DOI":"10.3892\/mmr.2025.13433"},{"key":"7945_CR24","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11:785\u201397.","journal-title":"Nat Immunol"},{"key":"7945_CR25","doi-asserted-by":"publisher","first-page":"7624","DOI":"10.7150\/thno.72853","volume":"12","author":"A Giguelay","year":"2022","unstructured":"Giguelay A, Turtoi E, Khelaf L, Tosato G, Dadi I, Chastel T, Poul MA, Pratlong M, Nicolescu S, Severac D, Adenis A, Sgarbura O, Carrere S, Rouanet P, Quenet F, Ychou M, Pourquier D, Colombo PE, Turtoi A, Colinge J. The landscape of cancer-associated fibroblasts in colorectal cancer liver metastases. Theranostics. 2022;12:7624\u201339.","journal-title":"Theranostics"},{"key":"7945_CR26","doi-asserted-by":"publisher","first-page":"5797","DOI":"10.1038\/s41467-022-33598-x","volume":"13","author":"L Monteran","year":"2022","unstructured":"Monteran L, Ershaid N, Doron H, Zait Y, Scharff Y, Ben-Yosef S, Avivi C, Barshack I, Sonnenblick A, Erez N. Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer. Nat Commun. 2022;13:5797.","journal-title":"Nat Commun"},{"key":"7945_CR27","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.21037\/jgo-22-965","volume":"13","author":"L Lin","year":"2022","unstructured":"Lin L, Zeng X, Liang S, Wang Y, Dai X, Sun Y, Wu Z. Construction of a co-expression network and prediction of metastasis markers in colorectal cancer patients with liver metastasis. J Gastrointest Oncol. 2022;13:2426\u201338.","journal-title":"J Gastrointest Oncol"},{"key":"7945_CR28","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney J, Dienstmann R, Wang X, de Reynies A, Schlicker A, Soneson C, Marisa L, Roepman P, Nyamundanda G, Angelino P, Bot BM, Morris JS, Simon IM, Gerster S, Fessler E, De Sousa EMF, Missiaglia E, Ramay H, Barras D, Homicsko K, Maru D, Manyam GC, Broom B, Boige V, Perez-Villamil B, Laderas T, Salazar R, Gray JW, Hanahan D, Tabernero J, Bernards R, Friend SH, Laurent-Puig P, Medema JP, Sadanandam A, Wessels L, Delorenzi M, Kopetz S, Vermeulen L, Tejpar S. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21:1350\u20136.","journal-title":"Nat Med"},{"key":"7945_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41525-021-00223-7","volume":"6","author":"PW Eide","year":"2021","unstructured":"Eide PW, Moosavi SH, Eilertsen IA, Brunsell TH, Langerud J, Berg KCG, Rosok BI, Bjornbeth BA, Nesbakken A, Lothe RA, Sveen A. Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer. NPJ Genom Med. 2021;6:59.","journal-title":"NPJ Genom Med"},{"key":"7945_CR30","doi-asserted-by":"publisher","first-page":"1160052","DOI":"10.3389\/fimmu.2023.1160052","volume":"14","author":"Y Lu","year":"2023","unstructured":"Lu Y, Gu D, Zhao C, Sun Y, Li W, He L, Wang X, Kou Z, Su J, Guo F. Genomic landscape and expression profile of consensus molecular subtype four of colorectal cancer. Front Immunol. 2023;14:1160052.","journal-title":"Front Immunol"},{"key":"7945_CR31","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s10555-024-10177-8","volume":"43","author":"S Malik","year":"2024","unstructured":"Malik S, Sikander M, Wahid M, Dhasmana A, Sarwat M, Khan S, Cobos E, Yallapu MM, Jaggi M, Chauhan SC. Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance. Cancer Metastasis Rev. 2024;43:981\u201399.","journal-title":"Cancer Metastasis Rev"},{"key":"7945_CR32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1158\/1078-0432.CCR-22-2041","volume":"29","author":"A Sathe","year":"2023","unstructured":"Sathe A, Mason K, Grimes SM, Zhou Z, Lau BT, Bai X, Su A, Tan X, Lee H, Suarez CJ, Nguyen Q, Poultsides G, Zhang NR, Ji HP. Colorectal Cancer Metastases in the Liver Establish Immunosuppressive Spatial Networking between Tumor-Associated SPP1\u2009+\u2009Macrophages and Fibroblasts. Clin Cancer Res. 2023;29:244\u201360.","journal-title":"Clin Cancer Res"},{"key":"7945_CR33","doi-asserted-by":"publisher","first-page":"101231","DOI":"10.1016\/j.xcrm.2023.101231","volume":"4","author":"P Qin","year":"2023","unstructured":"Qin P, Chen H, Wang Y, Huang L, Huang K, Xiao G, Han C, Hu J, Lin D, Wan X, Zheng Y, Liu Y, Li G, Yang H, Ye S, Luo M, Fu Y, Xu H, Wen L, Guo Z, Shen X, Li Z, Wang C, Chen X, Wang L, Sun L, Ren D, Wu L, Wang J, Liu S, Lin H. Cancer-associated fibroblasts undergoing neoadjuvant chemotherapy suppress rectal cancer revealed by single-cell and spatial transcriptomics. Cell Rep Med. 2023;4:101231.","journal-title":"Cell Rep Med"},{"key":"7945_CR34","doi-asserted-by":"publisher","first-page":"790096","DOI":"10.3389\/fonc.2022.790096","volume":"12","author":"MS Huang","year":"2022","unstructured":"Huang MS, Fu LH, Yan HC, Cheng LY, Ru HM, Mo S, Wei CY, Li DM, Mo XW, Tang WZ, Yan LH. Proteomics and liquid biopsy characterization of human EMT-related metastasis in colorectal cancer. Front Oncol. 2022;12:790096.","journal-title":"Front Oncol"},{"key":"7945_CR35","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s11033-024-09965-w","volume":"51","author":"Z Kalaei","year":"2024","unstructured":"Kalaei Z, Shekarchi AA, Hojjat-Farsangi M, Jalali P, Jadidi-Niaragh F. The prognostic and therapeutic potential of vimentin in colorectal cancer. Mol Biol Rep. 2024;51:1027.","journal-title":"Mol Biol Rep"},{"key":"7945_CR36","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/onc.2015.139","volume":"35","author":"F Guo","year":"2016","unstructured":"Guo F, Wang Y, Liu J, Mok SC, Xue F, Zhang W. CXCL12\/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks. Oncogene. 2016;35:816\u201326.","journal-title":"Oncogene"},{"key":"7945_CR37","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.ccell.2020.05.005","volume":"37","author":"Y Shen","year":"2020","unstructured":"Shen Y, Wang X, Lu J, Salfenmoser M, Wirsik NM, Schleussner N, Imle A, Freire Valls A, Radhakrishnan P, Liang J, Wang G, Muley T, Schneider M, Ruiz C, de Almodovar A, Diz-Munoz T, Schmidt. Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer. Cancer Cell. 2020;37:800\u2013e817807.","journal-title":"Cancer Cell"},{"key":"7945_CR38","doi-asserted-by":"crossref","unstructured":"An S, Kim SK, Kwon HY, Kim CS, Bang HJ, Do H, Kim B, Kim K, Kim Y. Expression of immune-related and inflammatory markers and their prognostic impact in colorectal cancer patients. Int J Mol Sci. 2023;24.","DOI":"10.20944\/preprints202306.2179.v1"},{"key":"7945_CR39","doi-asserted-by":"crossref","unstructured":"Carmona-Rodriguez L, Martinez-Rey D, Fernandez-Acenero MJ, Gonzalez-Martin A, Paz-Cabezas M, Rodriguez-Rodriguez N, Perez-Villamil B, Saez ME, Diaz-Rubio E, Mira E, Manes S. SOD3 induces a HIF-2alpha-dependent program in endothelial cells that provides a selective signal for tumor infiltration by T cells. J Immunother Cancer. 2020;8.","DOI":"10.1136\/jitc-2019-000432"},{"key":"7945_CR40","doi-asserted-by":"crossref","unstructured":"Bessa X, Elizalde JI, Mitjans F, Pinol V, Miquel R, Panes J, Piulats J, Pique JM, Castells A. Leukocyte recruitment in colon cancer: role of cell adhesion molecules, nitric oxide, and transforming growth factor beta1. Gastroenterology. 2002;122:1122\u201332.","DOI":"10.1053\/gast.2002.32369"},{"key":"7945_CR41","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.4049\/jimmunol.160.8.3978","volume":"160","author":"KF Yoong","year":"1998","unstructured":"Yoong KF, McNab G, Hubscher SG, Adams DH. Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor-infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma. J Immunol. 1998;160:3978\u201388.","journal-title":"J Immunol"},{"key":"7945_CR42","doi-asserted-by":"publisher","first-page":"145990","DOI":"10.1016\/j.gene.2021.145990","volume":"808","author":"J Yu","year":"2022","unstructured":"Yu J, Yang K, Zheng J, Sun X, Zhao W. Establishment of a novel prognostic signature based on an identified expression profile of integrin superfamily to predict overall survival of patients with colorectal adenocarcinoma. Gene. 2022;808:145990.","journal-title":"Gene"},{"key":"7945_CR43","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1002\/jcb.25189","volume":"116","author":"C Pelillo","year":"2015","unstructured":"Pelillo C, Bergamo A, Mollica H, Bestagno M, Sava G. Colorectal Cancer Metastases Settle in the Hepatic Microenvironment Through alpha5beta1 Integrin. J Cell Biochem. 2015;116:2385\u201396.","journal-title":"J Cell Biochem"},{"key":"7945_CR44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.canlet.2015.07.039","volume":"368","author":"L Hui","year":"2015","unstructured":"Hui L, Chen Y. Tumor microenvironment: Sanctuary of the devil. Cancer Lett. 2015;368:7\u201313.","journal-title":"Cancer Lett"},{"key":"7945_CR45","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3389\/fimmu.2019.01078","volume":"10","author":"H Harjunpaa","year":"2019","unstructured":"Harjunpaa H, Llort Asens M, Guenther C, Fagerholm SC. Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment. Front Immunol. 2019;10:1078.","journal-title":"Front Immunol"},{"key":"7945_CR46","doi-asserted-by":"publisher","first-page":"106966","DOI":"10.1016\/j.intimp.2020.106966","volume":"88","author":"D Chen","year":"2020","unstructured":"Chen D, Wang H. The clinical and immune features of CD14 in colorectal cancer identified via large-scale analysis. Int Immunopharmacol. 2020;88:106966.","journal-title":"Int Immunopharmacol"},{"key":"7945_CR47","doi-asserted-by":"publisher","first-page":"26361","DOI":"10.1038\/s41598-024-77248-2","volume":"14","author":"Y Hua","year":"2024","unstructured":"Hua Y, Ma X, Zhao X, Wei X, Mu X, Zhang X. Characterization of metastasis-specific macrophages in colorectal cancer for prognosis prediction and immunometabolic remodeling. Sci Rep. 2024;14:26361.","journal-title":"Sci Rep"},{"key":"7945_CR48","doi-asserted-by":"publisher","first-page":"217452","DOI":"10.1016\/j.canlet.2025.217452","volume":"612","author":"Y Zhan","year":"2025","unstructured":"Zhan Y, Sun D, Gao J, Gao Q, Lv Y, Du T, Dong Y, Wang Y, Zhan H, Li J, Li P, Du L, Wang C. Single-cell transcriptomics reveals intratumor heterogeneity and the potential roles of cancer stem cells and myCAFs in colorectal cancer liver metastasis and recurrence. Cancer Lett. 2025;612:217452.","journal-title":"Cancer Lett"},{"key":"7945_CR49","doi-asserted-by":"crossref","unstructured":"Pecoraro A, Pagano M, Russo G, Russo A. Ribosome biogenesis and cancer: overview on ribosomal proteins. Int J Mol Sci. 2021;22.","DOI":"10.3390\/ijms22115496"},{"key":"7945_CR50","doi-asserted-by":"publisher","first-page":"20208","DOI":"10.1074\/jbc.M117.809012","volume":"292","author":"YK Lee","year":"2017","unstructured":"Lee YK, Lim JJ, Jeoun UW, Min S, Lee EB, Kwon SM, Lee C, Yoon G. Lactate-mediated mitoribosomal defects impair mitochondrial oxidative phosphorylation and promote hepatoma cell invasiveness. J Biol Chem. 2017;292:20208\u201317.","journal-title":"J Biol Chem"},{"key":"7945_CR51","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10585-020-10058-8","volume":"37","author":"H Voss","year":"2020","unstructured":"Voss H, Wurlitzer M, Smit DJ, Ewald F, Alawi M, Spohn M, Indenbirken D, Omidi M, David K, Juhl H, Simon R, Sauter G, Fischer L, Izbicki JR, Molloy MP, Nashan B, Schluter H, Jucker M. Differential regulation of extracellular matrix proteins in three recurrent liver metastases of a single patient with colorectal cancer. Clin Exp Metastasis. 2020;37:649\u201356.","journal-title":"Clin Exp Metastasis"},{"key":"7945_CR52","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41698-025-00892-y","volume":"9","author":"M Abdel Hamid","year":"2025","unstructured":"Abdel Hamid M, Pammer LM, Oberparleiter S, Gunther M, Amann A, Gruber RA, Mair A, Nocera FI, Ormanns S, Zimmer K, Gerner RR, Kocher F, Vorbach SM, Wolf D, Riedl JM, Huemer F, Seeber A. Multidimensional differences of right- and left-sided colorectal cancer and their impact on targeted therapies. NPJ Precis Oncol. 2025;9:116.","journal-title":"NPJ Precis Oncol"},{"key":"7945_CR53","doi-asserted-by":"publisher","first-page":"zcae017","DOI":"10.1093\/narcan\/zcae017","volume":"6","author":"SP Hwang","year":"2024","unstructured":"Hwang SP, Denicourt C. The impact of ribosome biogenesis in cancer: from proliferation to metastasis. NAR Cancer. 2024;6:zcae017.","journal-title":"NAR Cancer"},{"key":"7945_CR54","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1158\/0008-5472.CAN-21-4087","volume":"82","author":"AR Elhamamsy","year":"2022","unstructured":"Elhamamsy AR, Metge BJ, Alsheikh HA, Shevde LA, Samant RS. Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance. Cancer Res. 2022;82:2344\u201353.","journal-title":"Cancer Res"},{"key":"7945_CR55","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1158\/1078-0432.CCR-14-2290","volume":"21","author":"TT Vellinga","year":"2015","unstructured":"Vellinga TT, Borovski T, de Boer VC, Fatrai S, van Schelven S, Trumpi K, Verheem A, Snoeren N, Emmink BL, Koster J, Rinkes IH, Kranenburg O. SIRT1\/PGC1alpha-Dependent Increase in Oxidative Phosphorylation Supports Chemotherapy Resistance of Colon Cancer. Clin Cancer Res. 2015;21:2870\u20139.","journal-title":"Clin Cancer Res"},{"key":"7945_CR56","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1126\/science.aay0939","volume":"367","author":"RY Ebright","year":"2020","unstructured":"Ebright RY, Lee S, Wittner BS, Niederhoffer KL, Nicholson BT, Bardia A, Truesdell S, Wiley DF, Wesley B, Li S, Mai A, Aceto N, Vincent-Jordan N, Szabolcs A, Chirn B, Kreuzer J, Comaills V, Kalinich M, Haas W, Ting DT, Toner M, Vasudevan S, Haber DA, Maheswaran S, Micalizzi DS. Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis. Science. 2020;367:1468\u201373.","journal-title":"Science"},{"key":"7945_CR57","doi-asserted-by":"publisher","first-page":"13008","DOI":"10.1038\/s41598-019-49477-3","volume":"9","author":"A Labriet","year":"2019","unstructured":"Labriet A, Levesque E, Cecchin E, De Mattia E, Villeneuve L, Rouleau M, Jonker D, Couture F, Simonyan D, Allain EP, Buonadonna A, D\u2019Andrea M, Toffoli G, Guillemette C. Germline variability and tumor expression level of ribosomal protein gene RPL28 are associated with survival of metastatic colorectal cancer patients. Sci Rep. 2019;9:13008.","journal-title":"Sci Rep"},{"key":"7945_CR58","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s12276-022-00765-5","volume":"54","author":"Y Sung","year":"2022","unstructured":"Sung Y, Yoon I, Han JM, Kim S. Functional and pathologic association of aminoacyl-tRNA synthetases with cancer. Exp Mol Med. 2022;54:553\u201366.","journal-title":"Exp Mol Med"},{"key":"7945_CR59","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1158\/1055-9965.EPI-09-0456","volume":"18","author":"A Ghanipour","year":"2009","unstructured":"Ghanipour A, Jirstrom K, Ponten F, Glimelius B, Pahlman L, Birgisson H. The prognostic significance of tryptophanyl-tRNA synthetase in colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2009;18:2949\u201356.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"7945_CR60","doi-asserted-by":"crossref","unstructured":"Chen HH, Waghorn PA, Wei L, Tapias LF, Schuhle DT, Rotile NJ, Jones CM, Looby RJ, Zhao G, Elliott JM, Probst CK, Mino-Kenudson M, Lauwers GY, Tager AM, Tanabe KK, Lanuti M, Fuchs BC, Caravan P. Molecular imaging of oxidized collagen quantifies pulmonary and hepatic fibrogenesis. JCI Insight. 2017;2.","DOI":"10.1172\/jci.insight.91506"},{"key":"7945_CR61","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12967-023-04810-3","volume":"22","author":"J Xiong","year":"2024","unstructured":"Xiong J, Xiao R, Zhao J, Zhao Q, Luo M, Li F, Zhang W, Wu M. Matrix stiffness affects tumor-associated macrophage functional polarization and its potential in tumor therapy. J Transl Med. 2024;22:85.","journal-title":"J Transl Med"},{"key":"7945_CR62","doi-asserted-by":"publisher","first-page":"e2401254","DOI":"10.1002\/advs.202401254","volume":"11","author":"L Qi","year":"2024","unstructured":"Qi L, Duan BW, Wang H, Liu YJ, Han H, Han MM, Xing L, Jiang HL, Pandol SJ, Li L. Reactive Oxygen Species-Responsive Nanoparticles Toward Extracellular Matrix Normalization for Pancreatic Fibrosis Regression. Adv Sci (Weinh). 2024;11:e2401254.","journal-title":"Adv Sci (Weinh)"},{"key":"7945_CR63","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1186\/s12967-024-05559-z","volume":"22","author":"LM Skrip","year":"2024","unstructured":"Skrip LM, Moosburner S, Tang P, Guo J, Gorner S, Tzschatzsch H, Bruggemann K, Walter KA, Hosse C, Fehrenbach U, Arnold A, Modest D, Krenzien F, Schoning W, Malinka T, Pratschke J, Papke B, Kas JA, Sack I, Sauer IM, Hillebrandt KH. Viscoelastic properties of colorectal liver metastases reflect tumour cell viability. J Transl Med. 2024;22:774.","journal-title":"J Transl Med"},{"key":"7945_CR64","doi-asserted-by":"crossref","unstructured":"Sobierajska K, Wawro ME, Niewiarowska J. Oxidative stress enhances the TGF-beta2-RhoA-MRTF-A\/B axis in cells entering endothelial-mesenchymal transition. Int J Mol Sci. 2022;23.","DOI":"10.3390\/ijms23042062"},{"key":"7945_CR65","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ccell.2022.02.013","volume":"40","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhang Q, Xing B, Luo N, Gao R, Yu K, Hu X, Bu Z, Peng J, Ren X, Zhang Z. Immune phenotypic linkage between colorectal cancer and liver metastasis. Cancer Cell. 2022;40:424\u2013e437425.","journal-title":"Cancer Cell"},{"key":"7945_CR66","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1245\/s10434-015-4778-7","volume":"23","author":"S Downs-Canner","year":"2016","unstructured":"Downs-Canner S, Magge D, Ravindranathan R, O\u2019Malley ME, Francis L, Liu Z, Sheng Guo Z, Obermajer N, Bartlett DL. Complement Inhibition: A Novel Form of Immunotherapy for Colon Cancer. Ann Surg Oncol. 2016;23:655\u201362.","journal-title":"Ann Surg Oncol"},{"key":"7945_CR67","doi-asserted-by":"crossref","unstructured":"Lawal B, Tseng SH, Olugbodi JO, Iamsaard S, Ilesanmi OB, Mahmoud MH, Ahmed SH, Batiha GE, Wu ATH. Pan-cancer analysis of immune complement signature C3\/C5\/C3AR1\/C5AR1 in association with tumor immune evasion and therapy resistance. Cancers (Basel). 2021;13.","DOI":"10.3390\/cancers13164124"},{"key":"7945_CR68","doi-asserted-by":"publisher","first-page":"110851","DOI":"10.1016\/j.celrep.2022.110851","volume":"39","author":"P Ding","year":"2022","unstructured":"Ding P, Xu Y, Li L, Lv X, Li L, Chen J, Zhou D, Wang X, Wang Q, Zhang W, Liao T, Ji QH, Lei QY, Hu W. Intracellular complement C5a\/C5aR1 stabilizes beta-catenin to promote colorectal tumorigenesis. Cell Rep. 2022;39:110851.","journal-title":"Cell Rep"},{"key":"7945_CR69","doi-asserted-by":"publisher","first-page":"e357","DOI":"10.1038\/oncsis.2017.48","volume":"6","author":"K Trumpi","year":"2017","unstructured":"Trumpi K, Ubink I, Trinh A, Djafarihamedani M, Jongen JM, Govaert KM, Elias SG, van Hooff SR, Medema JP, Lacle MM, Vermeulen L, Borel Rinkes IHM, Kranenburg O. Oncogenesis. 2017;6:e357. Neoadjuvant chemotherapy affects molecular classification of colorectal tumors.","journal-title":"Oncogenesis"},{"key":"7945_CR70","doi-asserted-by":"publisher","first-page":"101026","DOI":"10.1016\/j.mcpro.2025.101026","volume":"24","author":"P Nissen","year":"2025","unstructured":"Nissen P, Popova NV, Gocke A, Smit DJ, Wong GYM, McKay MJ, Hugh TJ, David K, Juhl H, Voss H, Marquardt JU, Nashan B, Schluter H, Molloy MP, Jucker M. Proteomic Landscape of Colorectal Cancer Derived Liver Metastasis Reveals Three Distinct Phenotypes With Specific Signaling and Enhanced Survival. Mol Cell Proteom. 2025;24:101026.","journal-title":"Mol Cell Proteom"},{"key":"7945_CR71","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12014-023-09407-y","volume":"20","author":"C Verathamjamras","year":"2023","unstructured":"Verathamjamras C, Chantaraamporn J, Sornprachum T, Mutapat P, Chokchaichamnankit D, Mingkwan K, Luevisadpibul V, Srisomsap C, Chutipongtanate S, Svasti J, Champattanachai V. Label-free quantitative proteomics reveals aberrant expression levels of LRG, C9, FN, A1AT and AGP1 in the plasma of patients with colorectal cancer. Clin Proteom. 2023;20:15.","journal-title":"Clin Proteom"},{"issue":"1","key":"7945_CR72","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1016\/S0140-6736(15)60410-X","volume":"385","author":"P Sutton","year":"2015","unstructured":"Sutton P, Evans J, Jones R, Malik H, Vimalachandran D, Palmer D, Goldring C, Kitteringham N. Proteomic analysis to identify biomarkers in the primary tumour that predict response to neoadjuvant chemotherapy in liver metastases. Lancet. 2015;385(1):S95.","journal-title":"Lancet"},{"key":"7945_CR73","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.ccell.2020.08.002","volume":"38","author":"C Li","year":"2020","unstructured":"Li C, Sun YD, Yu GY, Cui JR, Lou Z, Zhang H, Huang Y, Bai CG, Deng LL, Liu P, Zheng K, Wang YH, Wang QQ, Li QR, Wu QQ, Liu Q, Shyr Y, Li YX, Chen LN, Wu JR, Zhang W, Zeng R. Integrated Omics of Metastatic Colorectal Cancer. Cancer Cell. 2020;38:734\u2013e747739.","journal-title":"Cancer Cell"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07945-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07945-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07945-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:24:35Z","timestamp":1781637875000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07945-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7945"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07945-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"6 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients provided written informed consent for tissue sampling prior to surgery. The study was approved by the Charit\u00e9 ethics committee (approval numbers: EA1\/214\/19 and EA4\/132\/22) and was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have provided their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No competing financial interests exist.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 disclosure statements"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"487"}}